Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiologic Monitoring of Venlafaxine in Normal Controls
NCT00759317Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2001
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Venlafaxine with Placebo (2 arms). Primary endpoint: Quantitative EEG cordance at 7 days. Started Jun 2001; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00759317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759317.